The Wisconsin Angel Network, with assistance from students enrolled in Issues in Science and Technology Communication, a University of Wisconsin - Madison course, has collected early-stage investing success stories. 

2009

Addiction Therapeutix, Inc.

AimsBio

Dog Company Start-ups: White Bear Technologies and Unique Beast

Eso-Technologies

FiberMX LLC

Flying Cart LLC

FLEx

Flex Biomedical, Inc.

Genostx LLC 

Green Start-ups: PosiPair, AEC, Inc., and PeaPod Homes, LLC

HarQen

Innovative Sports Strategies

Mendotasoft LLC

PhysioGenix

Scopia 

Shoe Company Start-ups: Spira Footwear and NxtMile

Silica Solar LLC

Sologear LLC


2008

2DX2 Geothermal System

ABA Lifeline Interactive

BioIonix

BrainFruit

Career Extenders

Composite Rebar Technology

Drive Alternatives

EarthMimic

NeuroGenomeX

NxtMile

PeaPod

Platypus Technologies

ProactiCare

So-Lo Guitar

Steinbine Systems

Ven-T Boats

WEBbeams


2007

Quintessence

Cranberry

Skill Associates

Paradigm Sensors
 

Brain Reactions

EraGen

GetIPIC

GreenLeaf Market

intellimentor

Quincy Bioscience

Stemina Biomarkers

The Luggage Club

2006

Transitions Inc.

SmoxRox

Omnipresent Sysems

My Dwelling LLC

MoCo Market

Mail Foundry

GuestBridge Inc.

Inspire Industries

ESolutionsOnline.com

Esker Technologies

Colby Pharmaceuticals: Prostate cancer prevention drug gaining investment support

RNs To Go

Santal Solutions: Continues Success with New Product Launch


2005

Extract Systems: Finding success by changing directions

Marvel Medtech: Making strides in the fight against breast cancer

aOva: Success lies in the mouths of poultry and swine

AquaSensors: Finding synergy in Wisconsin

JobSightUSA: Aims to improve the job searching process

Mithridion: Serendipity helps company fighting against Alzheimer's

Orion Energy Systems: Bringing bright ideas to market

Small Tree: Succeeding alongside Apple

Pan Vera: Small start for biotech company leads to big business

 

GenTel BioSciences: Uses biochip in fight against cancer 

 

BellBrook Labs: Discovers its biotech niche